维普中文期刊产品整合服务
29篇 您的检索式:作者名="Yaeger R"
    题名 作者 年代 出处 被引量
1BRAF突变提示转移性结直肠癌患者转移灶切除术后预后不良显示文摘BRAF突变发生于5%~11%的转移性结直肠癌患者。该研究分析了BRAF突变患者转移灶切除术后的临床病理因素、PIK3CA突变频率以及预后情况。研究通过回顾性的对2009年至2012年单中心1941例转移性结直肠癌患者行KRAS/BRAF突变检测,共检出92例患者含BRAF突变。2011年423例BRAF野生型转移性肠癌患者作为对照组。 研究发现在转移性大肠癌中,与BRAF野生型组相比,BRAF突变型与确诊时高龄、女性、肿瘤位于右侧以及低分化、粘液组织形态更加相关。 BRAF突变更多出现于肠癌分期III期、T4期患者。 PIK3C与5%的BRAF突变共存,与17%的KRAS突变共存,与4%的BRAF/KRAS共突变共存。 BRAF突变的患者一般不只局限于肝转移,更容易出现腹膜转移。研究人员进一步研究发现合并BRAF突变的转移性肠癌患者转移灶相对不容易切除,即使切除后总生存期也较短。Yaeger R Cercek A Chou JF 2014中华结直肠疾病电子杂志2014,3,2:13
2Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer显示文摘Misale S Yaeger R Hobor S 2012Nature2012,486,7404:1
3Laboratory investigation of PRRS virus infection in three swine herds显示文摘Zemen D Neiger R Yaeger M 1993Vet Diagn Invest1993,5,:1
4Immunohistochemical evalu- ation of substance P and calcitonin gene-related peptide in skin and peri- osteum after extracorporeal shock wave therapy and radial pressure wave therapy in sheep显示文摘Abed J M McClure S R Yaeger M J 2007Am J Vet Res2007,68,3:1
5Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer显示文摘Misale S Yaeger R Hobor S 2012Nature2012,486,7404:1
6Emergence of KRASmutations and acquired resistance to anti 一 EGFR therapy in color-ectal cancer显示文摘MISALE S YAEGER R HOBOR S 2012Nature2012,486,7404:1
7Emergence of KRASmutations and acquired resistance to anti-EGFR therapy in color-ectal cancer显示文摘MISALE S YAEGER R HOBOR S 2012Nature2012,486,7404:1
8Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer显示文摘Misale S Yaeger R Hobor S 2012Nature2012,486,7404:1
9Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer 显示文摘Misale S Yaeger R Hobor S 2012Nature2012,486,7404:1
10Emergence of KRAS muta- tions and acquired resistance to anti-EGFR therapy in colorectal cancer 显示文摘Misale S Yaeger R Hobor S 2012Nature2012,486,7404:1
11Emergence ofKRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer显示文摘Misale S Yaeger R Hobor S 2012Nature2012,486,7404:1
12Genomic alterations observed in colitis - associated cancers are distinct from those found in sporadic colorectal cancers and vary by type of inflammatory bowel disease 显示文摘YAEGER R SHAH M A MILLER V A 2016Gastroenterology2016,,:1
13Impact of somatic mutations on patterns of metastasis in coloreetal cancer显示文摘Lipsyc M Yaeger R 2015J Gastrointest Oncol2015,6,6:1
14Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer显示文摘Misale S Yaeger R Hobor S 2012Nature2012,486,7404:1
15Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer 显示文摘Misale S Yaeger R Hobor S 2012Nature2012,486,7404:1
16Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer 显示文摘Misale S Yaeger R Hobor S 2012Nature2012,486,7404:1
1717β-HSD 2 may be higher in African-American breast cancer and is associated with estrogen receptor-negative tumors显示文摘Yaeger R Nolan PC Su T 2007Cancer Genomics Proteomics2007,4,5:1
18Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer 显示文摘MISALE S YAEGER R HOBOR S 2012Nature2012,486,7404:1
19Character-ization of an improved extraction chromatographic materi-al for the separation and preconcentration of strontium from acidic media显示文摘DIETZ M L YAEGER J SAJDAK J L R 2005Separation Science and Technology2005,40,:1
20Possible prevention of PMWS using inactivated PCV2 vaccine in CDCD pigs显示文摘POGRANICHNIY R YOONL K-J YAEGER M 2004Hamburg Germany:Proceedings of the 18th IPVS Congress2004,1,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费